Similar articles

• [OCULAR COMPLICATIONS CAUSED BY SYNTHETIC ANTIMALARIALS].

  PAUFIQUE L, GRANGE J, LEOPOLD P, RAVAULT MP. PAUFIQUE L, et al. Bull Soc Ophtalmol Fr. 1964 Oct;64:836-40. Bull Soc Ophtalmol Fr. 1964. PMID: 14306103 French. No abstract available.
• [THE THERAPEUTIC RISK: OCULAR DISEASES OF THERAPEUTIC ORIGIN].

  LABRAM C. LABRAM C. Concours Med. 1964 Sep 19;86:5117-20. Concours Med. 1964. PMID: 14199186 French. No abstract available.
• THE SUPERIORITY OF STEROID-OCCLUSIVE THERAPY FOR BROMODERMA.

  CAPLAN RM, SULLIVAN RR. CAPLAN RM, et al. Br J Dermatol. 1964 Mar;76:146-7. doi: 10.1111/j.1365-2133.1964.tb14494.x. Br J Dermatol. 1964. PMID: 14128268 No abstract available.
• [OCULAR COMPLICATIONS FOLLOWING THERAPY WITH QUININE AND ITS SYNTHETIC DERIVATIVES].

  PIATKOWSKA B. PIATKOWSKA B. Pol Tyg Lek. 1964 Aug 10;19:1250-3. Pol Tyg Lek. 1964. PMID: 14200545 Review. Polish. No abstract available.
• LIDS, LACRIMAL APPARATUS, AND CONJUNCTIVA.

  CALKINS LL. CALKINS LL. Arch Ophthalmol. 1965 Jan;73:131-41. doi: 10.1001/archopht.1965.00970030133028. Arch Ophthalmol. 1965. PMID: 14223674 Review. No abstract available.